Hypertension drives heart failure through metabolic and mitochondrial dysfunction. Catestatin restores metabolic flexibility in CSTKO hearts, shifts fuel use, and enhances ATP synthase activity, revealing a therapeutic endocrine–mitochondrial axis.
- Satadeepa Kal
- Venkat R. Chirasani
- Sushil K. Mahata